Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES LAGERKRANTZ GROUP IN CONNECTION WITH ACQUISIITON OF LANDAUER NORDIC
Mandate

VINGE ADVISES LAGERKRANTZ GROUP IN CONNECTION WITH ACQUISIITON OF LANDAUER NORDIC

October 01, 2015

Vinge has advised Lagerkrantz Group in connection with the acquisition of Landauer Nordic from Landauer, Inc. Landauer Nordic develops and sells products and services for the measurement of radon. The company’s headquarters are situated in Uppsala and the company has a subsidiary in Chicago, USA. Landauer Nordic has an annual turnover of SEK 40 million with good profitability.

Vinge’s team consisted of partner Johan Winnerblad together with, among others, associates Filip Öhrner, Carl Sander, Evelina Tejle and Rebecka Weitzberg.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025